Please sign in to follow a disease.
Sticky foam aims to improve mammogram positioning and comfort
NCT ID NCT07388940
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests MammoGRIP, a foam adhesive that helps technicians position the breast during mammography. Researchers want to see if it improves image quality and reduces the need for repeat scans. The study will enroll 50 women aged 40-75 getting routine mammograms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MammoGRIP (a topical foam adhesive device)
- What this could lead to
- If it works, this could make mammograms more comfortable and reduce the need for repeat images.
- What could go wrong
- This is a small pilot study with only 50 participants, so results may not apply to everyone. The device may not improve image quality or comfort significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 75 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 40-75 years undergoing routine screening or diagnostic mammography * Ability to provide informed consent * Prior mammogram results are available for the patient in Epic Exclusion Criteria: * History of bilateral mastectomy * Active skin condition or open wounds on the breast or chest * Known allergy to components of MammoGRIP®
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mammography are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Englewood Hospital
Englewood, New Jersey, 07647, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple search strategy boost breast cancer detection?
- Can AI read the hidden clues in mammograms?
- Phone nudges vs. cancer: can a simple app message save lives?
- New study aims to curb unnecessary mammograms in women over 75
- Tailored letters boost breast cancer screening in Hard-to-Reach women
- New mammogram tech put to the test in 7,500 women